- Home
- LGVN vs UPXI Comparison
LGVN vs UPXI Comparison
Compare LGVN & UPXI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LGVN
- UPXI
- Stock Information
- Founded
- LGVN 2014
- UPXI 2018
- Country
- LGVN United States
- UPXI United States
- Employees
- LGVN N/A
- UPXI N/A
- Industry
- LGVN Medicinal Chemicals and Botanical Products
- UPXI Medicinal Chemicals and Botanical Products
- Sector
- LGVN Health Care
- UPXI Health Care
- Exchange
- LGVN Nasdaq
- UPXI Nasdaq
- Market Cap
- LGVN 23.4M
- UPXI 356.9M
- IPO Year
- LGVN 2021
- UPXI 2021
- Fundamental
- Price
- LGVN $1.42
- UPXI $6.05
- Analyst Decision
- LGVN Strong Buy
- UPXI
- Analyst Count
- LGVN 3
- UPXI 0
- Target Price
- LGVN $8.67
- UPXI N/A
- AVG Volume (30 Days)
- LGVN 707.2K
- UPXI 4.7M
- Earning Date
- LGVN 08-13-2025
- UPXI 05-16-2025
- Dividend Yield
- LGVN N/A
- UPXI N/A
- EPS Growth
- LGVN N/A
- UPXI N/A
- EPS
- LGVN N/A
- UPXI N/A
- Revenue
- LGVN $2,225,000.00
- UPXI $16,562,327.00
- Revenue This Year
- LGVN N/A
- UPXI $299.03
- Revenue Next Year
- LGVN $51.48
- UPXI N/A
- P/E Ratio
- LGVN N/A
- UPXI N/A
- Revenue Growth
- LGVN 127.50
- UPXI 1378.83
- 52 Week Low
- LGVN $1.14
- UPXI $1.90
- 52 Week High
- LGVN $4.88
- UPXI $22.57
- Technical
- Relative Strength Index (RSI)
- LGVN 54.27
- UPXI 44.83
- Support Level
- LGVN $1.37
- UPXI $2.73
- Resistance Level
- LGVN $1.40
- UPXI $3.47
- Average True Range (ATR)
- LGVN 0.12
- UPXI 0.69
- MACD
- LGVN 0.02
- UPXI 0.14
- Stochastic Oscillator
- LGVN 46.43
- UPXI 36.97
About LGVN Longeveron Inc.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
About UPXI Upexi Inc.
Upexi Inc specializes in the development, manufacturing, and distribution of consumer products. It reaches consumers through its direct-to-consumer network, wholesale partnerships, and prominent third-party platforms like Amazon.